Investigative Site #102 — Nashville, Tennessee

Investigative Site #102 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site #102 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer.

Sponsors: MOMA Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site #102?

Investigative Site #102 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site #102 conducted?

Investigative Site #102 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer.

Is Investigative Site #102 accredited by Crixeo Clinical Trials?

Investigative Site #102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site #102?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.